SK132596A3 - The use of dimeticone for the local antibacterial therapy and/or the prevention and therapy of helicobacter pylori (hp) associated syndromes and infectious diseases - Google Patents
The use of dimeticone for the local antibacterial therapy and/or the prevention and therapy of helicobacter pylori (hp) associated syndromes and infectious diseases Download PDFInfo
- Publication number
- SK132596A3 SK132596A3 SK1325-96A SK132596A SK132596A3 SK 132596 A3 SK132596 A3 SK 132596A3 SK 132596 A SK132596 A SK 132596A SK 132596 A3 SK132596 A3 SK 132596A3
- Authority
- SK
- Slovakia
- Prior art keywords
- therapy
- dimeticone
- prevention
- helicobacter pylori
- infectious diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4409410 | 1994-03-18 | ||
PCT/EP1995/000972 WO1995025525A1 (en) | 1994-03-18 | 1995-03-15 | The use of dimeticone for the local antibacterial therapy and/or the prevention and therapy of helicobacter pylori (hp) associated syndromes and infectious diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
SK132596A3 true SK132596A3 (en) | 1997-08-06 |
Family
ID=6513239
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1325-96A SK132596A3 (en) | 1994-03-18 | 1995-03-15 | The use of dimeticone for the local antibacterial therapy and/or the prevention and therapy of helicobacter pylori (hp) associated syndromes and infectious diseases |
Country Status (13)
Country | Link |
---|---|
US (1) | US5834004A (zh) |
EP (1) | EP0759761A1 (zh) |
JP (1) | JPH09510465A (zh) |
CN (1) | CN1146154A (zh) |
AU (1) | AU706351B2 (zh) |
CA (1) | CA2185883C (zh) |
CZ (1) | CZ300696A3 (zh) |
FI (1) | FI963683A (zh) |
HU (1) | HUT75710A (zh) |
NO (1) | NO963892L (zh) |
NZ (1) | NZ282804A (zh) |
SK (1) | SK132596A3 (zh) |
WO (1) | WO1995025525A1 (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1097456C (zh) * | 1997-12-22 | 2003-01-01 | 永信药品工业股份有限公司 | 胃肠消泡锭剂的制造方法及其应用 |
US6279577B1 (en) | 1998-12-21 | 2001-08-28 | Carl A. Savaiano | Supporter |
FR2793688B1 (fr) * | 1999-05-21 | 2003-06-13 | Ethypharm Lab Prod Ethiques | Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques |
US6100245A (en) * | 1999-09-07 | 2000-08-08 | Mcneil-Ppc, Inc. | Use of simethicone to treat ulcerative colitis |
CN1288730A (zh) * | 1999-09-07 | 2001-03-28 | 麦克内尔-Ppc股份有限公司 | 轻泻组合物 |
KR100442174B1 (ko) * | 2001-09-25 | 2004-07-30 | (주)다산메디켐 | 이산화규소, 폴리소르베이트류 및디메칠폴리실록산(디메치콘, 시메치콘)을 함유하는소화기장애에 사용되는 고형의 신규의약조성물 |
US7252846B2 (en) * | 2004-05-28 | 2007-08-07 | Raied Dinno | Topical composition and method for the treatment and prophylaxis of dermal irritations |
DE102008037168A1 (de) | 2008-08-06 | 2010-06-24 | Nowak, Götz, Prof. Dr. | Verwendung von Sauerstoff zur Behandlung von Erkrankungen der Schleimhaut des Magen-Darm-Kanals |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3848M (fr) * | 1964-05-04 | 1966-01-17 | Robert Schapiro | Associations thérapeutiques pour traitement de nombreux troubles digestifs organiques ou fonctionnels. |
GB1357737A (en) * | 1970-10-09 | 1974-06-26 | Arpic Sa | Sustained release pharmaceutical compositions |
NZ217844A (en) * | 1985-10-11 | 1989-10-27 | Sumitomo Pharma | A sustained release pharmaceutical composition containing silicone elastomer and an albumin |
DE3642853A1 (de) * | 1986-12-16 | 1988-06-23 | Ulrich Von Dr Ing Pidoll | Arzneimittel |
US4960764A (en) * | 1987-03-06 | 1990-10-02 | Richardson-Vicks Inc. | Oil-in-water-in-silicone emulsion compositions |
US4837029A (en) * | 1987-04-06 | 1989-06-06 | Carolina Medical Products, Inc. | Low foaming, aqueously homogenizable rifampin composition |
DE3807712A1 (de) * | 1987-07-25 | 1989-02-02 | Nordend Apotheke Angela Hein | Arzneimittel-trockenpraeparat zur bereitung einer laxativ wirkenden trinkloesung sowie ein verfahren zur herstellung dieses praeparates |
US5446070A (en) * | 1991-02-27 | 1995-08-29 | Nover Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
EP0406248B1 (de) * | 1989-01-19 | 1994-06-08 | Alfred Schmidt | Verwendung von dimethylpolysiloxan zur behandlung von erkrankungen des gastrointestinaltraktes |
US5422093A (en) * | 1989-07-28 | 1995-06-06 | Queen's University | Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof |
IE903302A1 (en) * | 1989-09-15 | 1991-04-10 | Pehrom Pharmaceutical Corp | Topical preparation for treatment of aphthous ulcers and¹other lesions |
IN171919B (zh) * | 1989-11-01 | 1993-02-06 | Mcneil Ppc Inc | |
US5229137A (en) * | 1992-05-06 | 1993-07-20 | Brigham And Women's Hospital, Inc. | Methods and pharmaceutical compositions for treating episodic heartburn |
AU4682193A (en) * | 1992-07-29 | 1994-03-03 | Merck & Co., Inc. | Dexibuprofen/antacid/simethicone combinations |
-
1995
- 1995-03-15 AU AU20714/95A patent/AU706351B2/en not_active Ceased
- 1995-03-15 WO PCT/EP1995/000972 patent/WO1995025525A1/en not_active Application Discontinuation
- 1995-03-15 HU HU9602841A patent/HUT75710A/hu unknown
- 1995-03-15 SK SK1325-96A patent/SK132596A3/sk unknown
- 1995-03-15 JP JP7524362A patent/JPH09510465A/ja not_active Withdrawn
- 1995-03-15 US US08/716,161 patent/US5834004A/en not_active Expired - Lifetime
- 1995-03-15 CN CN95192556A patent/CN1146154A/zh active Pending
- 1995-03-15 CZ CZ963006A patent/CZ300696A3/cs unknown
- 1995-03-15 EP EP95913129A patent/EP0759761A1/en not_active Withdrawn
- 1995-03-15 CA CA002185883A patent/CA2185883C/en not_active Expired - Fee Related
- 1995-03-15 NZ NZ282804A patent/NZ282804A/xx unknown
-
1996
- 1996-09-17 FI FI963683A patent/FI963683A/fi unknown
- 1996-09-17 NO NO963892A patent/NO963892L/no unknown
Also Published As
Publication number | Publication date |
---|---|
HU9602841D0 (en) | 1996-12-30 |
WO1995025525A1 (en) | 1995-09-28 |
CN1146154A (zh) | 1997-03-26 |
FI963683A (fi) | 1996-11-13 |
EP0759761A1 (en) | 1997-03-05 |
JPH09510465A (ja) | 1997-10-21 |
FI963683A0 (fi) | 1996-09-17 |
CA2185883A1 (en) | 1995-09-28 |
NZ282804A (en) | 2000-12-22 |
US5834004A (en) | 1998-11-10 |
AU706351B2 (en) | 1999-06-17 |
HUT75710A (en) | 1997-05-28 |
NO963892D0 (no) | 1996-09-17 |
AU2071495A (en) | 1995-10-09 |
CZ300696A3 (en) | 1997-09-17 |
NO963892L (no) | 1996-11-04 |
CA2185883C (en) | 2005-08-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Graham et al. | Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing: a randomized controlled trial | |
Hosking et al. | Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial | |
Oderda et al. | Campylobacter pylori gastritis: long term results of treatment with amoxycillin. | |
Marshall | One hundred years of discovery and rediscovery of Helicobacter pylori and its association with peptic ulcer disease | |
Axon | Helicobacter pylori infection | |
Ramakrishna et al. | Aegle marmelos fruit extract attenuates Helicobacter pylori Lipopolysaccharide induced oxidative stress in Sprague Dawley rats | |
EP1112074B1 (en) | Taurolidine and/or taurultam against infectious ulcer or gastritis | |
SK132596A3 (en) | The use of dimeticone for the local antibacterial therapy and/or the prevention and therapy of helicobacter pylori (hp) associated syndromes and infectious diseases | |
Nariman et al. | Antibacterial activity of twenty Iranian plant extracts against clinical isolates of Helicobacter pylori | |
Figueroa et al. | Low H. pylori reinfection rate after triple therapy in Chilean duodenal ulcer patients. | |
Louw et al. | Triple therapy with sucralfate is as effective as triple therapy containing bismuth in eradicating Helicobacter pylori and reducing duodenal ulcer relapse rates | |
US4959384A (en) | Use of nitrofurantoin for the treatment and prophylaxis of gastrointestinal disorders | |
Catalano et al. | Helicobacter pylori-Positive Functional Dyspepsia in Elderly Patients Comparison of Two Treatments | |
Labenz et al. | Effective treatment after failure of omeprazole plus amoxycillin to eradicate Helicobacter pylori infection in peptic ulcer disease | |
AU699199B2 (en) | The use of dimeticone for the local antibacterial therapy and/or the prevention and therapy of helicobacter pylori (HP) associated syndromes and infectious diseases | |
US5229380A (en) | Method for treating helicobacter pylori gastritis | |
Ohkusa et al. | Prospective evaluation of a new anti‐ulcer agent, ecabet sodium, for the treatment of Helicobacter pylori infection | |
US6028062A (en) | Use of dimeticone for the local antibacterial therapy and/or the prevention and therapy of helicobacter pylori (Hp) associated syndromes and infectious diseases | |
Archimandritis et al. | Triple therapy eradicated H. pylori equally in patients pretreated with omeprazole or ranitidine: a 12-month follow-up | |
Slomiany et al. | Sucralfate affects the susceptibility of Helicobacter pylori to antimicrobial agents | |
Lee et al. | Evaluation of therapeutic regimens for the treatment of Helicobacter pylori infection | |
Dalla Libera et al. | High effectiveness and safety of one‐week antibiotic regimen in Helicobacter pylori eradication | |
SAITA et al. | Factors influencing Helicobacter pylori eradication with 2 week combination therapy of lansoprazole and amoxycillin: intragastric distribution of colonization and gastric mucosal atrophy | |
Levi et al. | Campylobacter pylori, duodenal ulcer disease, and gastrin. | |
Huesca et al. | Therapeutics used to alleviate peptic ulcers inhibit H. pylori receptor binding in vitro |